Ultime notizie per Ascent Industries (NASDAQ:ACNT) Azioni

Ascent Industries

Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Specialty Chemicals and Tubular Products. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive, and commercial transportation, brewery, chemical, petrochemical, and other industries. The Specialty Chemicals segment produces specialty products for pulp and paper, coatings, adhesives, sealants, and elastomers (CASE), textile, automotive, household, and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.

Wall Street Bull

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

ACNT

Le valutazioni estreme aprono scenari inaspettati, mentre alcuni titoli ipervenduti mostrano segnali di possibile ripresa.

Titoli ipervenduti: quali aziende potrebbero sorprendere il mercato?

TROX

Scopri i 3 titoli del settore materiali con RSI basso che potrebbero offrire opportunità di acquisto oggi.

3 titoli del settore dei materiali da tenere d&#39;occhio oggi

Ascent Industries Co

Oppenheimer analyst Ken Wong maintains Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) with a Outperform and raises the price target from $300 to $350.

Price Target

Analyst Ratings

ADSK

Oppenheimer Maintains Outperform on Autodesk, Raises Price Target to $350

Mizuho analyst Vikram Malhorta maintains UDR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UDR#NYSE">UDR</a>) with a Neutral and lowers the price target from $45 to $41.

Mizuho Maintains Neutral on UDR, Lowers Price Target to $41

LQDA

Trading Halt: Halted at 1:52:20 p.m. ET - Trading Halt: Halt News Pending

Uranium- and <a href="https://www.benzinga.com/etfs">nuclear-themed ETFs</a> spiked sharply Friday after news emerged that the domestic nuclear industry is set to be overhauled with executive orders from President Donald Trump.
Policy-driven optimism sent nuclear-themed ETFs—spanning reactor developers to uranium miners—soaring on a wave of investor interest. With Trump signaling long-term support, this momentum may have staying power.
Global X Uranium ETF Leads The Charge
The Global X Uranium ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URA#NYSE">URA</a>), a key benchmark for uranium stocks, jumped 11% Friday, driven by gains in top uranium miners and component makers. URA led all thematic ETFs for the day.
The North Shore Global Uranium Mining ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URNM#NYSE">URNM</a>) and VanEck Uranium+Nuclear Energy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLR#NYSE">NLR</a>) also surged around 9%, as broad momentum lifted nuclear stocks. These funds continue to attract investors seeking diversified, liquid exposure to a sector highly sensitive to policy and geopolitical shifts.
Also Read: <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/05/45591555/trump-targets-eu-apple-with-tariff-threats-etfs-could-feel-the-heat">Trump Targets EU, Apple With Tariff Threats: ETFs Could Feel The Heat</a>
What&#8217;s Driving The Rally
A growing narrative is fueling the rally: nuclear power may gain new policy support. Reuters reports Trump plans to invoke the Defense Production Act to declare a national emergency over U.S. dependence on foreign uranium and fast-track approvals for domestic reactors and infrastructure.
This comes as U.S. electricity demand rises for the first time in 20 years, driven by energy-hungry AI and data centers. With solar and wind constrained by storage and reliability issues, nuclear is gaining traction as a stable alternative.
ETFs Provide Focused Exposure Amid Volatility
While spot uranium miners like Uranium Energy Corp. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UEC#AMEX">UEC</a>), Energy Fuels Inc. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UUUU#AMEX">UUUU</a>), and Snow Lake Resources (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITM#NASDAQ">LITM</a>) <a href="https://www.benzinga.com/news/mid-cap/25/05/45587750/uranium-stocks-surge-trumps-nuclear-push-sparks-double-digit-gains">experienced double-digit increases</a>, up 23.7%, 16.0%, and 13.2% respectively, ETF investors enjoyed diversified exposure that lessens single-stock risk. URA, for example, has more than 40 holdings across mining, utility, and nuclear technology names.
In addition to miners, ETFs also picked up on the upside in more advanced nuclear companies such as Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) and Nano Nuclear Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNE#NASDAQ">NNE</a>), which surged more than 27% each in response to news of Trump&#8217;s policy initiatives. Utility stocks such as Constellation Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) and Vistra Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) also added to ETF returns.
Investor Implications 
For investors seeking exposure without the volatility of individual stocks, nuclear-themed ETFs offer an attractive alternative. Fund flows could accelerate if executive orders signal a lasting policy shift toward nuclear energy.
These ETFs also benefit from rising institutional demand for clean, reliable power, especially as AI-driven energy needs grow. Analysts note that a sustained rally in uranium prices, driven by supply constraints, could lift uranium-heavy ETFs as well.
Conclusion
Trump's nuclear energy push has reignited interest in a long-overlooked sector. As the political landscape shifts, ETF investors are positioning for a potential long-term energy pivot. Uranium and nuclear ETFs now reflect the intersection of policy, innovation, and surging tech-driven power demand.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45585283/trump-tariff-threat-hits-europe-stocks-sink-as-50-duties-loom">Trump Tariff Threat Hits Europe: Stocks Sink As 50% Duties Loom</a></li>
</ul>
Photo: Shutterstock

Sector ETFs

ETFs

LITM

OKLO

URNM

UUUU

Trump Sparks Uranium Frenzy: Nuclear ETFs See Explosive Gains

DA Davidson analyst Michael Baker maintains Advance Auto Parts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) with a Neutral and raises the price target from $45 to $47.

DA Davidson Maintains Neutral on Advance Auto Parts, Raises Price Target to $47

Mizuho analyst Vikram Malhotra maintains Mid-America Apartment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAA#NYSE">MAA</a>) with a Neutral and lowers the price target from $166 to $161.

Mizuho Maintains Neutral on Mid-America Apartment, Lowers Price Target to $161

Canaccord Genuity analyst Matthew Lee maintains Toronto-Dominion Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TD#TSX">TD</a>) with a Buy and raises the price target from C$96 to C$101.

TSX:TD

Canaccord Genuity Maintains Buy on Toronto-Dominion Bank, Raises Price Target to C$101

Mizuho analyst Vikram Malhorta maintains Essex Property Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESS#NYSE">ESS</a>) with a Outperform and lowers the price target from $314 to $293.

Mizuho Maintains Outperform on Essex Property Trust, Lowers Price Target to $293

Wall Street analysts rerated Autodesk, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) after the company reported <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45575552/autodesk-stock-climbs-after-better-than-expected-q1-results-raised-fy26-guidance" rel="noreferrer noopener">first-quarter results</a> after Thursday&#8217;s closing bell.
Autodesk reported quarterly earnings of&nbsp;$2.29&nbsp;per share, which beat the analyst consensus estimate of&nbsp;$2.15. Quarterly revenue of $1.63 billion beat the Street estimate of&nbsp;$1.61 billion&nbsp;and is up from revenue of&nbsp;$1.42 billion&nbsp;from the same period last year.
Autodesk expects second-quarter adjusted EPS of $2.44-$2.48, versus the $2.34 analyst estimate, and revenue of $1.72 billion-$1.73 billion, versus the $1.7 billion estimate.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/03/44398387/activist-investor-starboard-targets-autodesks-board-with-proxy-battle-report" rel="noreferrer noopener">Activist Investor Starboard Targets Autodesk&#8217;s Board With Proxy Battle &#8211; Report</a>
The company raised its fiscal 2026 adjusted EPS guidance from $9.34-$9.67&nbsp;to $9.50-$9.73 versus the $9.52&nbsp;estimate. Autodesk raised its fiscal revenue guidance from $6.89 billion-$6.96 billion&nbsp;to&nbsp;$6.92 billion-$7 billion, versus the $6.93 billion estimate.
<ul class="wp-block-list">
<li>Keybanc analyst Jason Celino maintained Autodesk with an Overweight and raised the <a href="https://www.benzinga.com/quote/ADSK/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $323 to $350</a>.</li>
<li>Stifel analyst Adam Borg reiterated Autodesk with a Buy and raised the price target from $310 to $350.</li>
</ul>
Keybanc: Celino noted that Autodesk reported better first-quarter revenue of $1.63 billion (15% Y/Y) versus Street&#8217;s $1.61 billion. The analyst said the higher revenue and continued cost discipline drove an operating margin of 37% (39% adjusted), ahead of Street&#8217;s 35.6%.
While Autodesk has not seen any material macro impact yet, it is being prudent and lowering its fiscal 2026 normalized constant currency (CC) billings growth outlook by 1 point to 16%-18%, with the low end contemplating new business growth to decelerate to a similar rate as the pandemic level and EBA renewal uplift rates to deteriorate, he noted.
While it also baked similar prudence into its revenue outlook, that is offset by the fiscal first-quarter outperformance and layering of first-half bookings in the second half, resulting in Autodesk maintaining its full-year normalized CC revenue growth guidance of 8%-9%, Celino said.
With the second-half normalized CC revenue outlook implying growth decelerating to 7%-8% (versus first-quarter&#8217;s organic 10%), Celino noted Autodesk&#8217;s revenue guidance is relatively conservative. Full-year reported operating margin and free cash flow guidance are moving slightly higher to 36.5%-37% and $2.1 billion-$2.2 billion, respectively, a touch better than consensus of 36.5% and $2.14 billion, to reflect the company&#8217;s ongoing cost discipline, the analyst added.
Stifel: Autodesk delivered a solid fiscal first-quarter print, with revenue, operating margin, and EPS above Borg and street expectations and Billings above Autodesk expectations, as underlying CC billings growth and revenue growth improved sequentially.
Despite the more elevated macro uncertainty, the analyst noted that Autodesk cited no change in fundamentals, with solid linearity, and Autodesk closed the second-largest deal in company history. He said that Autodesk continues to work through the transaction model along with the GTM restructuring.
While the macro remains the wildcard, Borg noted that Autodesk&#8217;s story is beginning to clean up and that this quarter demonstrated the resilience of Autodesk&#8217;s business model.
Looking ahead, the analyst stated that guidance remains conservative. He remained bullish on Autodesk&#8217;s strategy and remarked that the company has a number of drivers to sustain at least high-single-digit top-line growth and improve profitability in the coming years.
Price Action: ADSK shares traded lower by 0.08% at $294.74 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45590448/why-is-apple-stock-sliding-on-friday" target="_blank" rel="noreferrer noopener">Why Is Apple Stock Sliding On Friday?</a></li>
</ul>
Photo by Piotr Swat via Shutterstock

Analyst Color

Reiteration

Autodesk Outlook Is Conservative But Macro Environment Is Still A Wildcard: Analyst

Mizuho analyst Vikram Malhorta maintains Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) with a Neutral and lowers the price target from $76 to $71.

Mizuho Maintains Neutral on Equity Residential, Lowers Price Target to $71

Mizuho analyst Vikram Malhorta maintains Camden Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPT#NYSE">CPT</a>) with a Outperform and lowers the price target from $130 to $122.

Mizuho Maintains Outperform on Camden Prop Trust, Lowers Price Target to $122

Barrington Research analyst Kevin Steinke maintains ACCO Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACCO#NYSE">ACCO</a>) with a Outperform and lowers the price target from $7 to $6.

ACCO

Barrington Research Maintains Outperform on ACCO Brands, Lowers Price Target to $6

Mizuho analyst Vikram Malhotra maintains AvalonBay Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVB#NYSE">AVB</a>) with a Outperform and lowers the price target from $238 to $213.

Mizuho Maintains Outperform on AvalonBay Communities, Lowers Price Target to $213

Barrington Research analyst Gary Prestopino maintains PowerFleet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIOT#NASDAQ">AIOT</a>) with a Outperform and maintains $15 price target.

AIOT

Barrington Research Maintains Outperform on PowerFleet, Maintains $15 Price Target

Mizuho analyst Anthony Petrone maintains Embecta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EMBC#NASDAQ">EMBC</a>) with a Neutral and lowers the price target from $15 to $13.

EMBC

Mizuho Maintains Neutral on Embecta, Lowers Price Target to $13

Mizuho analyst Ben Chaiken maintains Churchill Downs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHDN#NASDAQ">CHDN</a>) with a Outperform and lowers the price target from $137 to $134.

CHDN

Mizuho Maintains Outperform on Churchill Downs, Lowers Price Target to $134

Scotiabank analyst Mike Rizvanovic maintains Toronto-Dominion Bank (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TD#TSX">TD</a>) with a Sector Perform and raises the price target from C$90 to C$95.

Scotiabank Maintains Sector Perform on Toronto-Dominion Bank, Raises Price Target to C$95

<a href="https://www.salesforce.com/blog/flex-credits/">https://www.salesforce.com/blog/flex-credits/</a>

General

Salesforce Introduces New Unlimited Per-User, Per-Month License For Users In Sales, Customer Service & Industries

Article via <a href="https://elplanteo.com/reprocann-cambios-2025/">El Planteo</a>
Argentina&#8217;s Ministry of Health has published a sweeping new regulation reshaping how patients, caregivers, non-profit organizations and researchers can access and cultivate <a href="https://www.benzinga.com/cannabis">medical cannabis</a> in the country. The updated framework, enacted through Resolution 1780/2025, replaces prior rules and imposes stricter eligibility criteria and oversight mechanisms.
<h3 class="wp-block-heading">What Is REPROCANN?</h3>
The <a href="https://elplanteo.com/como-inscribirse-en-reprocann/">REPROCANN</a> (Registro del Programa de Cannabis) is Argentina's national medical cannabis registry. Created under Law 27.350 in 2017 and expanded through various decrees and resolutions, it allows patients and authorized third parties to legally grow cannabis for therapeutic use with medical approval. REPROCANN also provides legal safeguards against criminal prosecution under Argentina's narcotics law.
<h3 class="wp-block-heading">Key Changes Introduced In 2025</h3>
1. Categories redefined
The new regulation formalizes four distinct categories:
<ul class="wp-block-list">
<li>Patients (autocultivators): Individuals cultivating cannabis for their own treatment.</li>
<li>Third-party cultivators: Trusted individuals growing for a specific patient.</li>
<li>Civil associations &amp; foundations: Nonprofits authorized to grow for multiple patients.</li>
<li>Research &amp; development projects: Institutions conducting approved scientific studies on cannabis.</li>
</ul>
2. Updated permit durations
<ul class="wp-block-list">
<li>Patients (autocultivators): Permits valid for 3 years</li>
<li>All other categories (third parties, NGOs, researchers): Valid for 1 year</li>
</ul>
This distinction was originally introduced via Resolution 766/2023 and has now been reaffirmed. The shorter terms for non-patient entities aim to improve monitoring and patient safety.
3. Stricter oversight for non-patient cultivators
Third-party growers can only cultivate for themselves and one additional patient, must submit regular reports, provide detailed cultivation plans, and cannot have criminal records related to narcotics.
4. Higher standards for organizations
Nonprofit organizations and research institutions must:
<ul class="wp-block-list">
<li>Have clear cannabis-related objectives in their bylaws</li>
<li>Designate a Medical Director with certified cannabis training</li>
<li>Employ a Technical Cultivation Manager</li>
<li>Maintain strict patient confidentiality and traceability systems</li>
<li>Submit biannual progress and chromatographic reports</li>
</ul>
5. Mandatory physician qualifications
Doctors who prescribe cannabis under REPROCANN must now:
<ul class="wp-block-list">
<li>Be registered with Argentina's National Registry of Health Professionals (REFEPS)</li>
<li>Have formal training in cannabis medicine</li>
<li>Use digital signatures</li>
<li>Submit a new mandatory Informed Consent form (signed with each patient)</li>
</ul>
<h3 class="wp-block-heading">Why It Matters</h3>
Argentina is among the few Latin American countries with a legal homegrow system embedded in federal health policy. However, concerns over abuse, especially involving third-party growers operating outside of therapeutic bounds, have led to calls for greater control.
Also read: <a href="https://www.benzinga.com/markets/cannabis/25/05/45410084/legal-cannabis-10-years-later-real-data-from-the-first-country-to-do-it">Legal Cannabis, 10 Years Later: Real Data From The First Country To Do It</a>
By tightening eligibility and enhancing scientific and medical oversight, this new regulation aims to preserve patient access while preventing backdoor commercialization.
<h3 class="wp-block-heading">What About Existing REPROCANN Users?</h3>
Current permit holders are not immediately affected. However, all registrants must update their documentation within six months (by November 2025) to comply with the new rules, regardless of their permit's expiration date. Failure to do so will result in automatic revocation.
Note: While Argentina's cannabis exports remain limited and recreational use is still prohibited, its medical framework offers valuable insights for countries evaluating decentralized or homegrow-access models. The REPROCANN overhaul may signal a broader shift toward evidence-based cannabis policy in Latin America.
This article is from an external, unpaid contributor or content partner. It does not represent Benzinga's reporting and has not been edited for content or accuracy.

Cannabis

Latin America

Politics

New Cannabis Regulations In Argentina: Patients Keep Rights, Growers Face New Limits

Craig-Hallum analyst Eric Des Lauriers assumes Lindblad Expeditions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIND#NASDAQ">LIND</a>) with a Buy rating and announces Price Target of $16.

Initiation

LIND

Craig-Hallum Assumes Lindblad Expeditions at Buy, Announces Price Target of $16

Press Releases

Leading the Domestic Manufacturing Renaissance: Ascent Industries to Kick Off SOCMA 2025

Ascent Industries Sets Fourth Quarter and Full Year 2024 Earnings Conference Call for March 4, 2025, at 5:00 p.m. ET

Ascent Industries Reports Fourth Quarter and Full Year 2024 Results

Ascent Industries Co. Announces Sale of Bristol Metals, LLC for $45 Million

Ascent Industries Brings Performance-Driven Oil & Gas Solutions to AFPM 2025

Ascent Industries Co. Announces Successful Completion of Sale of Bristol Metals, LLC

Ascent Industries Co. Announces Multi-Year Specialty Chemicals Contract, Driving Significant EBITDA Growth

Ascent Industries Announces Upcoming Investor Conference Schedule

Ascent Industries Sets First Quarter 2025 Earnings Conference Call for May 12, 2025, at 5:00 p.m. ET

Ascent Industries Reports First Quarter 2025 Results

Alpha Metallurgical Resources, Inc. Common Stock

Alpha Metallurgical

Cleveland-Cliffs

Commercial Metals

Carpenter Technology Corporation Common Stock

Carpenter Tech

Friedman Indus

Gerdau

Warrior Met Coal

Ramaco Resources, Inc. - Class A Common Stock

Ramaco Resources

Ramaco Resources, Inc. - Class B Common Stock

Mesabi Tr

ArcelorMittal

Metallus

Nucor

POSCO HOLDINGS INC. American Depositary Shares (Each representing 1/4th of a share of Common Stock)

POSCO Holdings

Radius Recycling, Inc. - Class A Common Stock

Radius Recycling

Reliance

Ryerson Holding

Companhia Siderurgica Nacional S.A. Common Stock

Companhia Siderurgica

Steel Dynamics

SunCoke Energy

Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares, USD1.00 par value)

Comments

Ascent Industries

Notizie

Ultime notizie per Ascent Industries (NASDAQ:ACNT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO